The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease

Clinical Immunology

Volumn 109, Issue 1, 2003, Pages 17-28

  Ehrlich, Melanie ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; DNA METHYLTRANSFERASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEMBRANE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; REPETITIVE DNA;

AGAMMAGLOBULINEMIA; AMINO ACID SUBSTITUTION; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARABIDOPSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL DEATH; CELL LINE; CELL STIMULATION; CENTROMERE; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 21; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DNA BINDING; DNA METHYLATION; DNA MICROARRAY; DNA SEQUENCE; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME DEFICIENCY; EPICANTHUS; FACE DYSMORPHIA; FACE MALFORMATION; GENE MUTATION; GENE OVEREXPRESSION; GENETICS; GROWTH RETARDATION; HUMAN; ICF SYNDROME; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGY; IONIZING RADIATION; KARYOTYPING; LYMPHOBLASTOID CELL; LYMPHOMA; MAMMAL CELL; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SYMPTOMATOLOGY; TELANGIECTASIA; TELECANTHUS; THROMBOCYTE ACTIVATION; TUMOR SUPPRESSOR GENE; TWO DIMENSIONAL ELECTROPHORESIS; X CHROMOSOME;

EID: 0142216231     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00201-8     Document Type: Article

References (87)

1. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 98:1999;247-257.
2. Xu G., Bestor T.H., Bourc'his D., Hsieh C., Tommerup N., Hulten M., Qu S., Russo J.J., Viegas-Péquignot E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature. 402:1999;187-191.
3. Smeets D.F.C.M., Moog U., Weemaes C.M.R., Vaes-Peeters G., Merkx G.F.M., Niehof J.P., Hamers G. ICF syndrome a new case and review of the literature . Hum. Genet. 94:1994;240-246.
4. Jeanpierre M., Turleau C., Aurias A., Prieur M., Ledeist F., Fischer A., Viegas-Pequignot E. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum. Mol. Genet. 2:1993;731-735.
5. Gimelli G., Varone P., Pezzolo A., Lerone M., Pistoia V. ICF syndrome with variable expression in sibs. J. Med. Gen. 30:1993;429-432.
6. De Ravel T.J., Deckers E., Alliet P.L., Petit P., Fryns J.P. The ICF syndrome new case and update . Genet. Couns. 12:2001;379-385.
7. Brown D.C., Grace E., Summer A.T., Edmunds A.T., Ellis P.M. ICF syndrome (immunodeficiency, centromeric instability and facial anomalies) investigation of heterochromatin abnormalities and review of clinical outcome . Hum. Genet. 96:1995;411-416.
8. Fasth A., Forestier E., Holmberg E., Holmgren G., Nordenson I., Soderstrom T., Wahlstrom J. Fragllity of the centromeric region of chromosome 1 associated with combined immunodeficiency in siblings a recessively inherited entity . Acta Paediatr. Scand. 79:1990;605-612.
9. Sawyer J.R., Swanson C.M., Wheeler G., Cunniff C. Chromosome instability in ICF syndrome formation of micronuclei from multibranched chromosome 1 demonstrated by fluorescence in situ hybridization . Am. J. Med. Genet. 56:1995;203-209.
10. Tiepolo L., Maraschio P., Gimelli G., Cuoco C., Gargani G.F., Romano C. Multibranched chromosomes 1,9, and 16 in a patient with combined IgA and IgE deficiency. Hum. Genet. 51:1979;127-137.
11. Hulten M. Selective somatic pairing and fragility at 1q12 in a boy with common variable immunodeficiency. Clin. Genet. 14:1978;294.
12. Ostergaard P.A. A girl with recurrent infections, low IgM and an abnormal chromosome number 1. Acta Paediatr. Scand. 62:1973;211-215.
13. Shirohzu H., Kubota T., Kumazawa A., Sado T., Chijiwa T., Inagaki K., Suetake I., Tajima S., Wakui K., Miki Y., Hayashi M., Fukushima Y., Sasaki H. Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am. J. Med. Genet. 112:2002;31-37.
14. Wijmenga C., van den Heuvel L.P., Strengman E., Luyten J.A., van der Burgt I.J., de Groot R., Smeets D.F., Draaisma J.M., van Dongen J.J., De Abreu R.A., Pearson P.L., Sandkuijl L.A., Weemaes C.M. Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. Am. J. Hum. Genet. 63:1998;803-809.
15. Fryns J.P., Azou M., Jacken J., Eggermont E., Pedersen J.C., Van den Berghe H. Centromeric instability of chromosomes 1,9, and 16 associated with combined immunodeficiency. Hum. Genet. 57:1981;108-110.
16. Turleau C., Cabanis M.-O., Girault D., Ledeist F., Mettey R., Puissant H., Marguerite P., de Grouchy J. Multibranched chromosomes in the ICF syndrome immunodeficiency, centromeric instability, and facial anomalies . Am. J. Med. Genet. 32:1989;420-424.
17. Sumner A.T., Mitchell A.R., Ellis P.M. A FISH study of chromosome fusion in the ICF syndrome involvement of paracentric heterochromatin but not of the centromeres themselves . J. Med. Genet. 35:1998;833-835.
18. Tagarro I., Fernandez-Peralta A.M., Gonzalez-Aguilera J.J. Chromosomal localization of human satellites 2 and 3 by a FISH method using oligonucleotides as probes. Hum. Genet. 93:1994;383-388.
19. Tuck-Muller C.M., Narayan A., Tsien F., Smeets D., Sawyer J., Fiala E.S., Sohn O., Ehrlich M. DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogen. Cell Genet. 89:2000;121-128.
20. Miniou P., Jeanpierre M., Bourc'his D., Coutinho Barbosa A.C., Blanquet V., Viegas-Pequignot E. Alpha-satellite DNA methylation in normal individuals and in ICF patients heterogeneous methylation of constitutive heterochromatin in adult and fetal tissues . Hum. Genet. 99:1997;738-745.
21. Carpenter N.J., Fillpovich A., Blaese R.M., Carey T.L., Berkel A.I. Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1,9, and 16. J. Pediatr. 112:1988;757-760.
22. Maraschio P., Zuffardi O., Dalia Fior T., Tiepolo L. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1,9, and 16, and facial anomalies the ICF syndrome . J. Med. Genet. 25:1988;173-180.
23. Miniou P., Jeanpierre M., Blanquet V., Sibella V., Bonneau D., Herbelin C., Fischer A., Niveleau A., Viegas-Pequignot E.T. Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients. Hum. Mol. Genet. 3:1994;2093-2102.
24. Trinh B.N., Long T.I., Nickel A.E., Shibata D., Laird P.W. DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair. Mol. Cell Biol. 22:2002;2906-2917.
25. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science. 300:2003;489-492.
26. Ehrlich M. DNA methylation in cancer too much, but also too little . Oncogene. 21:2002;5400-5413.
27. Gowher H., Jeltsch A. Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases. J. Biol. Chem. 277:2002;20409-20414.
28. Bachman K.E., Rountree M.R., Baylin S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276:2001;32282-32287.
29. Kim G.D., Ni J., Kelesoglu N., Roberts R.J., Pradhan S. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21:2002;4183-4195.
30. Kang E.S., Park C.W., Chung J.H. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. Biochem. Biophys. Res. Commun. 289:2001;862-868.
31. Hemandez R., Frady A., Zhang X.-Y., Varela M., Ehrlich M. Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. Cytogenet. Cell Genet. 76:1997;196-201.
32. Ji W., Hemandez R., Zhang X.-Y., Qu G., Frady A., Varela M., Ehrlich M. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat. Res. 379:1997;33-41.
33. Wijmenga C., Hansen R.S., Gimelli G., Bjorck E.J., Davies E.G., Valentine D., Belohradsky B.H., van Dongen J.J., Smeets D.F., van den Heuvel L.P., Luyten J.A., Strengman E., Weemaes C., Pearson P.L. Genetic variation in ICF syndrome evidence for genetic heterogeneity . Hum. Mutat. 16:2000;509-517.
34. Narayan A., Ji W., Zhang X.-Y., Marrogi A., Graff J.R., Baylin S.B., Ehrlich M. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int. J. Cancer. 77:1998;833-838.
35. Ehrlich M., Buchanan K., Tsien F., Jiang G., Sun B., Uicker W., Weemaes C., Smeets D., Sperling K., Belohradsky B., Tommerup N., Misek D., Rouillard J.-M., Kuick R., Hanash S. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphocyte migration, activation, and survival genes. Hum. Mol. Genet. 10:2001;2917-2931.
36. Hansen R.S., Wijmenga C., Luo P., Stanek A.M., Canfield T.K., Weemaes C.M., Gartler S.M. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA. 96:1999;14412-14417.
37. Watanabe D., Suetake I., Tada T., Tajima S. Stage- and cell-specific expression of Dnmt3a and Dnmt3b during embryogenesis. Mech. Dev. 118:2002;187-190.
38. Rhee I., Bachman K.E., Park B.H., Jair K.W., Yen R.W., Schuebel K.E., Cui H., Feinberg A.P., Lengauer C., Kinzler K.W., Baylin S.B., Vogelstein B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 416:2002;552-556.
39. Kondo T., Comenge Y., Bobek M.P., Kuick R., Lamb B., Zhu X., Narayan A., Bourc'his D., Viegas-Pequinot E., Ehrlich M., Hanash S. Whole-genome methylation scan in ICF syndrome hypomethylation of non-satellite DNA repeats D4Z4 and NBL2 . Hum. Mol. Gen. 9:2000;597-604.
40. Hewitt J.E., Lyle R., Clark L.N., Valleley E.M., Wright T.J., Wijmenga C., van Deutekom J.C., Francis F., Sharpe P.T., Hofker M., et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum. Mol. Genet. 3:1994;1287-1295.
41. Thoraval D., Asakawa J., Wimmer K., Kuick R., Lamb B., Richardson B., Ambros P., Glover T., Hanash S. Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chromosomes Cancer. 17:1996;234-244.
42. Beckers M., Gabriels J., van der Maarel S., De Vriese A., Frants R.R., Collen D., Belayew A. Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. Gene. 264:2001;51-57.
43. Hansen R.S., Stoger R., Wijmenga C., Stanek A.M., Canfield T.K., Luo P., Matarazzo M.R., D'Esposito M., Feil R., Gimelli G., Weemaes C.M., Laird C.D., Gartler S.M. Escape from gene silencing in ICF syndrome evidence for advanced replication time as a major determinant . Hum. Mol. Genet. 9:2000;2575-2587.
44. Bourc'his D., Miniou P., Jeanpierre M., Molina Gomes D., Dupont J., De Saint-Basile G., Maraschio P., Tiepolo L., Viegas-Pequignot E. Abnormal methylation does not prevent X inactivation in ICF patients. Cytogenet. Cell Genet. 84:1999;245-252.
45. Schuffenhauer S., Bartsch O., Stumm M., Buchholz T., Petropoulou T., Kraft S., Belohradsky B., Meitinger T., Wegner R. DNA, FISH and complementation studies in ICF syndrome; DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor. Hum. Genet. 96:1995;562-571.
46. Tao Q., Huang H., Geiman T.M., Lim C.Y., Fu L., Qiu G.H., Robertson K.D. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum. Mol. Genet. 11:2002;2091-2102.
47. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 69:1992;915-926.
48. Bartee L., Malagnac F., Bender J. Arabidopsis cmt3 chromomethylase mutations block non-CG methylation and silencing of an endogenous gene. Genes Dev. 15:2001;1753-1758.
49. Ronemus M.J., Galbiati M., Ticknor C., Chen J., Dellaporta S.L. Demethylation-induced developmental pleiotropy in Arabidopsis. Science. 273:1996;654-657.
50. Tompa R., McCallum C.M., Delrow J., Henikoff J.G., van Steensel B., Henikoff S. Genome-wide profiling of DNA methylation reveals transposon targets of Chromomethylase3. Curr. Biol. 12:2002;65-68.
51. Berube N.G., Smeenk C.A., Picketts D.J. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum. Mol. Genet. 9:2000;539-547.
52. Gibbons R.J., McDowell T.L., Raman S., O'Rourke D.M., Garrick D., Ayyub H., Higgs D.R. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nature Genet. 24:2000;368-371.
53. Vongs A., Kakutani T., Martienssen R.A., Richards E.J. Arabidopsis thaliana DNA methylation mutants. Science. 260:1993;1926-1928.
54. Singer T., Yordan C., Martienssen R.A. Robertson's mutator transposons in A. thaliana are regulated by the chromatin-remodeling gene decrease in DNA methylation (DDM1). Genes Dev. 15:2001;591-602.
55. Dennis K., Fan T., Geiman T., Yan Q., Muegge K. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev. 15:2001;2940-2944.
56. Chedin F., Lieber M.R., Hsieh C.L. The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc. Natl. Acad. Sci. USA. 99:2002;16916-16921.
57. Aapola U., Liiv I., Peterson P. Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity. Nucleic Acids Res. 30:2002;3602-3608.
58. Jackson J.P., Lindroth A.M., Cao X., Jacobsen S.E. Control of CpNpG DNA methylation by the Kryptonite histone H3 methyltransferase. Nature. 416:2002;556-560.
59. Geiman T.M., Tessarollo L., Anver M.R., Kopp J.B., Ward J.M., Muegge K. Lsh, a SNF2 family member, is required for normal murine development. Biochim. Biophys. Acta. 1526:2001;211-220.
60. Bourc'his D., Xu G.L., Lin C.S., Bollman B., Bestor T.H. Dnmt3L and the establishment of maternal genomic imprints. Science. 294:2001;2536-2539.
61. Kakutani T., Jeddeloh J.A., Flowers S.K., Munakata K., Richards E.J. Developmental abnormalities and epimutations associated with DNA hypomethylation mutations. Proc. Natl. Acad. Sci. USA. 93:1996;12406-12411.
62. Reif K., Cyster J.G. RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J. Immunol. 164:2000;4720-4729.
63. Moratz C., Kang V.H., Druey K.M., Shi C.S., Scheschonka A., Murphy P.M., Kozasa T., Kehrl J.H. Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes. J. Immunol. 164:2000;1829-1838.
64. Berman D.M., Gilman A.G. Mammalian RGS proteins barbarians at the gate . J. Biol. Chem. 273:1998;1269-1272.
65. Lim S.P., Leung E., Krissansen G.W. The beta7 integrin gene (ltgb-7) promoter is responsive to TGF-beta1 defining control regions . Immunogenetics. 48:1998;184-195.
66. Laabi Y., Gras M.P., Brouet J.C., Berger R., Larsen C.J., Tsapis A. The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res. 22:1994;1147-1154.
67. Gras M.P., Laabi Y., Linares-Cruz G., Blondel M.O., Rigaut J.P., Brouet J.C., Leca G., Haguenauer-Tsapis R., Tsapis A. BCMAp an integral membrane protein in the Golgi apparatus of human mature B lymphocytes . Int. Immunol. 7:1995;1093-1106.
68. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C., Moore M., Littau A., Grossman A., Haugen H., Foley K., Blumberg H., Harrison K., Kindsvogel W., Clegg C.H. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:2000;995-999.
69. Xu S., Lam K.P. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol. Cell Biol. 21:2001;4067-4074.
70. Hatzoglou A., Roussel J., Bourgeade M.F., Rogier E., Madry C., Inoue J., Devergne O., Tsapis A. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165:2000;1322-1330.
71. Rao S., Karray S., Gackstetter E.R., Koshland M.E. Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter. J. Biol. Chem. 273:1998;26123-26129.
72. Swanson B.J., Jack H.M., Lyons G.E. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells MEF2C is a B cell-restricted transcription factor in lymphocytes . Mol. Immunol. 35:1998;445-458.
73. Wallin J.J., Rinkenberger J.L., Rao S., Gackstetter E.R., Koshland M.E., Zwollo P. B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development. J. Biol. Chem. 274:1999;15959-15965.
74. Futran J., Kemp J.D., Field E.H., Vora A., Ashman R.F. Transferrin receptor synthesis is an early event in B cell activation. J. Immunol. 143:1989;787-792.
75. Cheng P.C., Steele C.R., Gu L., Song W., Pierce S.K. MHC class II antigen processing in B cells accelerated intracellular targeting of antigens . J. Immunol. 162:1999;7171-7180.
76. Pan L., Sato S., Frederick J.P., Sun X.H., Zhuang Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell Biol. 19:1999;5969-5980.
77. Rivera R.R., Johns C.P., Quan J., Johnson R.S., Murre C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity. 12:2000;17-26.
78. Narayan A., Tuck-Muller C., Weissbecker K., Smeets D., Ehrlich M. Hypersensitivity to radiation-induced non-apoptotic and apoptotic death in cell lines from patients with the ICF chromosome instability syndrome. Mutat. Res. 456:2000;1-15.
79. z-selective RGS protein in brain. Structure, membrane association, regulation by G alpha, phosphorylation, and relationship to a Gz gtpase-activating protein subfamily. J. Biol. Chem. 273:1998;26014-26025.
80. Sabbattini P., Lundgren M., Georgiou A., Chow C., Warnes G., Dillon N. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J. 20:2001;2812-2822.
81. Gasser S.M. Positions of potential nuclear organization and gene expression . Cell. 104:2001;639-642.
82. Brown K.E., Baxter J., Graf D., Merkenschlager M., Fisher A.G. Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol. Cell. 3:1999;207-217.
83. Howard P.J., Lewis I.J., Harris F., Walker S. Centromeric instability of chromosomes 1 and 16 with variable immune deficiency a new syndrome . Clin. Genet. 27:1985;501-505.
84. Valkova G., Ghenev E., Tzancheva M. Centromeric instability of chromosomes 1, 9 and 16 with variable immune deficiency. Support of a new syndrome. Clin. Genet. 31:1987;119-124.
85. Kieback P., Wendisch H., Lorenz P., Hinkel K. ICF syndrome. Immunodeficiency, chromosomal centromere instability, facial anomalies. Case report and literature review. Monatsschr Kinderheilkd. 140:1992;91-94.
86. Franceschini P., Martino S., Ciocchini M., Ciuti E., Vardeu M.P., Guala A., Signorile F., Camerano P., Franceschini D., Tovo P.A. Variability of clinical and immunological phenotype in immunodeficiency-centromeric instability-facial anomalies syndrome. Report of two new patients and review of the literature. Eur. J. Pediatr. 154:1995;840-846.
87. Pezzolo A., Prigione I., Chiesa S., Castellano E., Gimelli G., Pistoia V. A novel case of immunodeficiency, centromeric instability, and facial anomalies (the ICF syndrome) immunologic and cytogenetic studies . Haematologica. 87:2002;329-331.